News & Events


Innovative clinical study: a successful step in COPD research

February 22, 2018

Great success in COPD research: An innovative clinical study performed by Fraunhofer ITEM has shown the drug under investigation to improve not only lung function in COPD patients, but to have a significantly positive effect on their heart function as well. The study investigated a combination drug from Novartis Pharma AG (indacaterol/glycopyrronium) that has already been approved for COPD treatment. The results were published in the renowned journal "The Lancet Respiratory Medicine".

read more

Phase-I drug interaction study in Crohn’s disease patients initiated

February 2, 2018

In close collaboration with the Clinic for Gastroenterology, Hepatology and Endocrinology at the Hannover Medical School, the potential of ustekinumab to interfere with the pharmacokinetics of midazolam, warfarin, omeprazole, dextromethorphan, and caffeine is being explored at the CRC Hannover in a phase-I study with patients with moderate to severe Crohn's disease.

read more

New sleep laboratory: first study with a new antidepressant drug

January 25, 2018

Fraunhofer ITEM has extended the diagnostic possibilities in its clinical research by setting up a sleep laboratory with 4 beds in the phase-I unit of the Clinical Research Center Hannover.

read more


November 24, 2017

In a clinical study for method validation, performed in close collaboration with the Institute for Radiology of the Hannover Medical School, scientists were able to demonstrate that functional MRI with arterial spin labeling is a reliable method for quantification of kidney perfusion.

read more

Observational study in cases of COPD

July 21, 2017

The lung disease, COPD, usually caused by smoking, is associated with chronic coughing and shortness of breath. It has a detrimental effect on quality of life and in its advanced stages, it is a frequent cause of death. Apart from pulmonary function tests, there have been no suitable biomarkers (biological parameters, for example certain blood-based messengers) in the bodies of those affected hitherto which indicate the severity or predict the progression of the disease. In a major international study, which the Fraunhofer ITEM is participating in, COPD patients having various degrees of severity and healthy ex-smokers are to be observed over a period of two years.

read more


ATS International Conference 2018

This year's annual conference of the American Thoracic Society (ATS) will be held from May 18 to 23 in San Diego, CA (USA). The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders.

go to event

DZL Annual Meeting 2018

From February 8 to 9, the German Center for Lung Research will hold its Annual Meeting 2018 in Bad Nauheim, Germany. Each year, scientists and junior researchers get together at this meeting to discuss a broad variety of topics related to lung diseases. For this year’s meeting, several Fraunhofer ITEM scientists have been selected to give oral presentations and to present their posters among the top ten posters in two disease areas.

go to event

17th Fraunhofer Seminar »Models of Lung Disease«

The 17th Fraunhofer Seminar "Models of Lung Disease" will be held in Hannover, Germany, on January 18 and 19, 2018.
Seating is limited - be sure not to miss this Event!

go to event

DZIF-Workshop of the Infrastructure Biobanking “Storage of biosamples”

October 9, 2017

The one-day workshop “Storage of biosamples” will take place on October 19th, 2017 at the CRC Hannover. The workshop is directed by the Hannover Unified Biobank (HUB), the central Biobank of the Hannover Medical School.

go to event

Workshop “Environmental Risk Assessment of Veterinary Medicinal Products – Update, Recent Developments and Implications”

November 9, 2017.

In cooperation with the German Federal Office of Consumer Protection and Food Safety (BVL), the Fraunhofer ITEM Department of Chemical Risk Assessment is offering a one-day workshop on environmental risk assessment of veterinary drugs on November 9, 2017.

go to event